AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sita OD MSR 100/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sita OD MSR 100/1000 Tablet ER

Diabetic patients with type 2 mellitus can manage elevated blood glucose with Sita OD MSR 100/1000 ER tablets, a dual-action medication. This formulation helps mitigate severe diabetic complications, such as renal impairment and vision loss, potentially lessening the risk of cardiovascular events like stroke or myocardial infarction. Sita OD MSR 100/1000 ER may be administered independently or alongside other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices significantly impact glycemic control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse event, especially when used concurrently with insulin or sulfonylureas; patients should learn hypoglycemia recognition and management. This medication isn't universally appropriate. Prior to commencing therapy, individuals with pre-existing hepatic, renal, or cardiac conditions, pancreatic dysfunction, or significant alcohol consumption should consult their physician. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate disclosure of all medications to the prescribing physician to ensure patient safety. Alcohol should be avoided due to its potential to exacerbate hypoglycemia. Renal function and glucose levels are monitored routinely throughout treatment.

Uses of Sita OD MSR 100/1000 Tablet ER

Managing type 2 diabetes

Major Benefits of Sita OD MSR 100/1000 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sita OD MSR 100/1000 Extended-Release tablets should be administered with a meal.

Common Side effects of Sita OD MSR 100/1000 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sita OD MSR 100/1000 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sita OD MSR 100/1000 Extended-Release tablets should be taken with meals.

How Sita OD MSR 100/1000 Tablet ER works:

Sita OD MSR 100/1000 Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action results in improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Sita OD MSR 100/1000 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sita OD MSR 100/1000 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sita OD MSR 100/1000 Tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Sita OD MSR 100/1000 Extended-Release tablets. Dosage modification may be necessary. Physician consultation is recommended. Sita OD MSR 100/1000 ER tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The extended-release Sita OD MSR 100/1000 tablet may pose significant risks for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Sita OD MSR 100/1000 Tablet ER :

Should you forget to take a Sita OD MSR 100/1000 Tablet ER, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Sita OD MSR 100/1000 Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Medication

FAQs on Sita OD MSR 100/1000 Tablet ER

Sita OD MSR 100/1000 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sita OD MSR 100/1000 Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia and neurological issues, manifesting as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sita OD MSR 100/1000 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Avoid Sita OD MSR 100/1000 Tablet ER if the patient has a known allergy to any ingredient or if they have severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sita OD MSR 100/1000 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sita OD MSR 100/1000 Tablet ER) can rarely cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sita OD MSR 100/1000 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sita OD MSR 100/1000 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sita OD MSR 100/1000 Tablet ER components or excipients should not use this medication. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol with Sita OD MSR 100/1000 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sita OD MSR 100/1000 Tablet ER) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or slow heart rate. If you experience these, stop taking the medication and seek immediate medical attention.
Prolonged use of Sita OD MSR 100/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sita OD MSR 100/1000 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sita OD MSR 100/1000 Tablet ER may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sita OD MSR 100/1000 Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sita OD MSR 100/1000 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Sita OD MSR 100/1000 Tablet ER) can rarely cause lactic acidosis, a serious medical emergency with dangerously high blood lactic acid levels (also called MALA, or Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, stop taking the medication and seek immediate medical attention.
Prolonged use of Sita OD MSR 100/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sita OD MSR 100/1000 Tabl...
124
MRP 144
13% off